AcellBia (rituximab biosimilar) / Biocad, Kocak Farma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AcellBia (rituximab biosimilar) / Biocad, Kocak Farma
BCD020a: A Study of the Efficacy and Safety of Rituximab bio similar study in Subjects With CD20-positive indolent non-Hodgkin lymphoma

Completed
3
92
India, Russian Federation, Ukraine
BCD-020 (rituximab biosimilar)
Biocad
NHL
 
 

Download Options